Lonza ups the ante in US with Merck KGaA deal, Samsung Biologics must respond

Coverage, in order

1. 3d ago
   
   Pharma Manufacturing obscure

   Lonza ups the ante in US with Merck KGaA deal, Samsung Biologics must respond

   With Lonza’s creation of arguably the largest biologics CDMO network in the U.S., Samsung’s limited beachhead in America won’t be enough to compete.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.